about
The TR2 and TR4 orphan nuclear receptors repress Gata1 transcriptionAn embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimerPGC-1 coactivator activity is required for murine erythropoiesis.Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genesClinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registryThe LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell miceIntestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease.Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouseProtective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.Proceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell DiseaseHematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemiaImpact of psychiatric diagnoses on hospital length of stay in children with sickle cell anemia.Design of the silent cerebral infarct transfusion (SIT) trial.Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease.Attitudes of Ghanaian women toward genetic testing for sickle cell trait.A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis.An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes.Coming of age with sickle cell disease and the role of patient as teacher.TR2/TR4 overexpression in a humanized sickle cell disease mouse model decreases RBC adhesion to VCAM-1.Medicine and the arts. Sickle cell vision: A patient's photographic illustration of coping [excerpt] by Heather L. Davis. Commentary.Who counsels parents of newborns who are carriers of sickle cell anemia or cystic fibrosis?Oxidative Profile of Patients with Sickle Cell DiseaseElevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients.Serum Iron Levels and Copper-to-Zinc Ratio in Sickle Cell Disease.Safety of gadolinium-based contrast material in sickle cell diseaseP-selectin glycoprotein ligand-1 inhibition blocks increased leukocyte-endothelial interactions associated with sickle cell disease in miceCorrelation Between Soluble Endothelial Adhesion Molecules and Nitric Oxide Metabolites in Sickle Cell DiseaseTricuspid Regurgitation Velocity and Other Biomarkers of Mortality in Children, Adolescents and Young Adults with Sickle Cell Disease in the United States: the PUSH StudyRed blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell diseaseIdentifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop ReportAn Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research
P50
Q24299134-65C30F48-9284-41FA-A494-184098B2DD0FQ24537021-B07A4C37-933B-496A-9C73-2B42907635FCQ33602602-73BBF683-2577-4981-82B3-6578CAF78B0EQ34456733-81072D98-06E7-46A0-BD20-BDC19E5D8189Q35096956-D0827D9E-DA40-485F-96FD-E26A53150969Q35859235-2250E92F-E978-4D06-A70C-25D06C352DF6Q36092963-9C2488DA-DA47-4336-9439-57F3CF47C715Q36366625-81DE8D45-7E0C-41C2-8F9A-157AAD642EA6Q36563588-8BB6218F-7834-4267-9B18-80E9C9865B64Q36657988-1564856B-969D-459D-B97F-2EFD54DFF3E9Q37014532-AE41D55E-CC8C-4DC4-9431-EAE873BD3DBEQ37372175-2B49E345-A460-4083-8A0B-5D3E04F354FBQ39769449-94C1D2D0-4088-45D2-BD4E-F30AE32BFC9BQ41527748-C1DAE1BB-4EA9-48A7-9696-968D5EFC1DDBQ45019137-6CD772D4-4F29-4B2E-B8F8-A7F5F192C7F4Q45911215-329826F2-14A9-476D-A02D-924F73B2FD2BQ48090580-154AB9EC-27BF-498B-8536-0E5112F49F92Q48249605-8369B75A-B3B9-41DF-B13D-0242428F4643Q50531951-367ADB5D-A130-4862-BB82-34B33B32192EQ50555827-20D85BBB-BA5F-4B2F-B422-9F7B1ACE57B2Q53070549-063EECA3-7913-4A98-9447-0A4B30F1B6BCQ53150478-23711AFF-A1C0-4577-BD93-C95ACDE65B68Q64252994-7130E916-D51A-43F6-90AB-EF11454A8E82Q64880487-ECC13448-F030-4F2A-9C98-1BF08BCB18C7Q64970475-1B58057E-FC06-4384-BF49-680E11DDDF3BQ84572127-DA32064D-595C-4358-BC59-5BE6A8B2032EQ85336426-1CF82655-BB30-4A6B-84F7-F335C4B053F0Q90706346-8CAF8C50-C6D8-4C15-A0D7-28531B93EB72Q91534900-6B21475F-814D-492D-B7C4-C19781EB40DDQ91543854-1859B25F-A21F-4FDD-8A8B-99357EAA3C7EQ93008736-A31EFA79-0F3E-428C-83AA-405817D3A878Q94955311-347B3569-FA52-41A6-9734-5C6BB2B00161
P50
description
researcher
@en
wetenschapper
@nl
name
A Campbell
@en
A Campbell
@nl
type
label
A Campbell
@en
A Campbell
@nl
prefLabel
A Campbell
@en
A Campbell
@nl
P106
P31
P496
0000-0002-8829-0043